- Filed
- May 10, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 9, 2024 | 3.43M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $0 |
| Capex | Q1 2024 · Mar 31, 2023 | $1K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $10.07M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $9.87M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $744K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $690K |
| Current Assets | Q1 2024 · Mar 31, 2024 | $13.28M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $13.14M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $14.54M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $14.45M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 3.43M sh |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$112K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $13.37M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $13.41M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $522K |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $268K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$44K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$138K |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $1.02M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $1.02M |